Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

41.59
Delayed Data
As of Sep 30
 -0.21 / -0.50%
Today’s Change
41.27
Today|||52-Week Range
59.00
-28.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Operating ActivitiesNet Income / Starting Line1.3B1.2B1.4B1.5B
 
 
 
 
 
Depreciation94.5M148.3M92.3M108.1M
 
 
 
 
 
Total Other Cash Flow289.0M160.1M143.0M208.1M
 
 
 
 
 
Funds From Operations1.6B1.5B1.6B1.8B
 
 
 
 
 
Funds From/For Other Operating Expenses-167.7M34.6M524.3M-357.5M
 
 
 
 
 
Net Cash Flow - Operating Activities1.8B1.5B1.1B2.2B
 
 
 
 
 
 
InvestingIncrease In Investments-300.9M-223.1M-72.5M-6.9M
 
 
 
 
 
Decrease In Investments887.0K-2.3M0.00301.8M
 
 
 
 
Capital Expenditures-185.8M-321.1M-161.3M-253.4M
 
 
 
 
 
Fixed Asset Disposal438.7K-862.2K0.00149.4K
 
 
 
 
Other Investing - Uses-29.0M29.0M0.000.00
 
 
 
Net Cash Flow Investing-491.2M-693.2M-241.2M31.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-744.4M-645.7M-555.3M-544.9M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-2.5M12.3M-2.4B-25.0M
 
 
 
 
 
Other Sources - Financing0.000.00415.7M-415.7M
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-746.8M-633.5M-2.5B-985.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-6.2M2.7M-19.7M6.8M
 
 
 
 
 
 
Net Change In Cash564.6M143.5M-1.7B1.2B